Previous Article | Next Article 
Journal of Bacteriology, October 1999, p. 6003-6009, Vol. 181, No. 19
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cloning and Characterization of a Cryptic Haloacid
Dehalogenase from Burkholderia cepacia MBA4
Jimmy S. H.
Tsang* and
Laiju
Sam
Molecular Microbiology Laboratory, Department
of Botany, The University of Hong Kong, Hong Kong
Received 5 March 1999/Accepted 5 July 1999
 |
ABSTRACT |
Burkholderia cepacia MBA4 has been shown to produce a
single dehalogenase batch culture. Moreover, other cryptic
dehalogenases were also detected when the cells were grown in
continuous culture. In this paper, we report the cloning and
characterization of one of the cryptic dehalogenases in MBA4. This
cryptic haloacid dehalogenase, designated Chd1, was expressed
constitutively in Escherichia coli. This recombinant Chd1
had a relative molecular weight of 58,000 and existed predominantly as
a dimer. The subunits had a relative molecular weight of 27,000. Chd1
exhibited isomer specificity, being active towards the
L-isomer of 2-monochloropropionic acid only. The structural
gene, chd1, was isolated on a 1.7-kb PstI fragment. This fragment contains a functional promoter, because expression of chd1 in E. coli is orientation
independent. The nucleotide sequence of this fragment was
determined and characterized. An open reading frame of 840 bp encoding
a putative peptide of 280 amino acids was identified. This
corresponds closely with the size of the subunit. The nucleotide
sequence of chd1 did not show any homology
with those of other dehalogenase genes. Comparison of the
predicted amino acid sequence, however, shows significant homology, ranging from 42 to 50%, with the amino acid sequences of
many other dehalogenases. Chd1 is unusual in having a long leader
sequence, a property of periplasmic enzymes.
 |
INTRODUCTION |
2-Haloacid dehalogenases, or
halidohydrolases, are hydrolytic enzymes that cleave the halogen-carbon
bond(s) in halogenated aliphatic acids, yielding hydroxy- or
oxoalkanoic acids from a substrate with a mono- or disubstitution,
respectively (14, 39). Burkholderia
cepacia MBA4 (formerly considered a
Pseudomonas species) was isolated from soil by batch
enrichment culture with monobromoacetic acid (MBA) as the sole carbon
and energy source. MBA4 is able to grow on MBA, monochloroacetate
(MCA), 2-mono-chloropropionate (2MCPA), and 2-monobromopropionate
(2MBPA) (43). This bacterium produces a single dehalogenase
(DehIVa) in batch culture, and this enzyme has been purified and
characterized (43). The active enzyme is a dimeric protein
of 45 kDa. The structural gene for DehIVa, hdlIVa, was
isolated from a genomic library (42), and analysis
of the DNA sequence revealed an open reading frame (ORF) for 231 amino
acids and a putative protein of 25.9 kDa (32).
Cryptic genes are silent DNA sequences; i.e., they are not normally
expressed in an individual (13). Previous studies suggest the presence of cryptic dehalogenases in the gene pools of some dehalogenase-producing bacteria (15, 19, 38, 40, 45). During
the course of studying the physiology of MBA4 in continuous culture,
other dehalogenases were also detected by activity-stained gel
electrophoresis and by a change in specific dehalogenase activity. These cells grew in a fraction of the maximum specific growth rate
(35a, 41). However, because of their lack of expression in
normal batch culture, the availability of these cryptic dehalogenases is scarce. It is therefore difficult to characterize these cryptic dehalogenases unless sufficient amounts of the enzymes can be obtained,
for example, by means of heterologous expression.
Producing an enzyme in a heterologous host requires the isolation of
the corresponding structural gene. Cloning and expression of the MBA4
hdlIVa gene in Pseudomonas putida and in
Escherichia coli suggested that the promoter of the
Burkholderia gene is not regulated in these foreign hosts
(42). These results provide the basis for the hypothesis
that genes normally silent in Burkholderia could be
expressed constitutively, although at a basal level, in E. coli. In this study, we report the cloning and characterization of
one of the cryptic dehalogenases found in B. cepacia MBA4.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and culture conditions.
B.
cepacia MBA4 (43) was used as the source of chromosomal
DNA. E. coli XL1-Blue MR (Stratagene) was used for library
construction, and strain TOP10F' (Invitrogen) was used as a host strain
for gene cloning and plasmid construction. Plasmid pSP73 (Promega) was
used as a cloning vector. B. cepacia was grown in an MBA
medium as described previously (43). Recombinant E. coli cells were grown at 37°C in Luria broth (1% tryptone,
0.5% yeast extract) with or without 0.5% NaCl and supplemented with
50 µg of ampicillin per ml. E. coli IT41 (20)
is temperature sensitive and was grown at 30°C unless otherwise specified.
Enzymes and chemicals.
Restriction endonucleases, T4 DNA
ligase, and sequencing oligonucleotide primers were obtained from
Gibco-BRL and Advanced Biotechnologies. Calf intestine alkaline
phosphate was purchased from Boehringer Mannheim. Deoxynucleotides and
a sequencing kit including Cy5-labelled fluorescent DNA were obtained
from Pharmacia. MCA was obtained from Sigma. All other chemicals were
of analytical grade.
DNA manipulation and transformation.
Restriction
endonuclease treatments, alkaline phosphatase treatments, and ligations
were performed according to the suppliers' recommended protocols.
Plasmid DNA was prepared with a Qiagen plasmid kit. For analytical
purposes, the boiling method of Holmes and Quigley (17) was
used. DNA fragments were purified with a GeneClean kit (Bio 101) after
agarose gel electrophoresis. Transformation of E. coli
TOP10F' with plasmid DNA was performed by the CaCl2 method
(8).
Construction of a genomic DNA library and screening of
dehalogenase-producing clones.
A genomic DNA library of B. cepacia MBA4 was constructed in the cosmid vector SuperCos1
according to the manufacturer's protocol (Stratagene). The library DNA
was packaged in vitro with Gigapack II XL packaging extract and
transfected into E. coli XL1-Blue MR. Putative
dehalogenase-producing transfectants were screened with a 96-well
microtiter plate with MCA as the reaction substrate as described
previously (32, 42). MCA was used because MBA is toxic to
E. coli cells and medium containing MBA inhibited the growth
of the bacterium (32, 42).
Preparation of total protein extract and activity-stained
PAGE.
Total protein extracts of the cells were prepared by
sonication (MSE Soniprep 150) or by two passages through a French press (SLM Aminco) at 40,000 lb/in2. The remaining whole cells
and cell debris were removed by centrifugation at 48,400 × g for 45 min. The relative mobilities of the dehalogenases were
analyzed by nondenaturing activity-stained polyacrylamide gel
electrophoresis (PAGE) (43) with MCA as the reaction
substrate. Crude protein extracts prepared from B. cepacia
MBA4 were used as positive controls to determine the relative
mobilities of the tested enzymes.
Dehalogenase and protein assays.
The dehalogenase assay was
routinely carried out with MCA as the substrate, owing to its better
stability than that of MBA. A standard assay mixture (1 ml) consisted
of 50 mM MCA, 20 mM Tris-sulfate buffer (pH 7.9), and enzyme and was
incubated at 30°C. The halide ions released were measured with a
Chloride Analyzer 925 (Corning). When the substrate concentration was
below 1 mM, chloride ions were determined spectrophotometrically
(3). Protein concentrations were determined with Bio-Rad
protein assay reagent.
Enzyme purification.
All steps were carried out at 0 to
5°C unless otherwise specified. All buffers contained 1 mM
phenylmethylsulfonyl fluoride and 1 mM EDTA to prevent inactivation of
the enzyme.
Step 1. Preparation of crude cell extracts.
Total protein
extracts were prepared as described above.
Step 2. Protamine sulfate precipitation.
Nucleic acids were
removed from the crude extract by protamine sulfate precipitation.
Protamine sulfate (0.4% [wt/vol] final concentration) was added to
the cell extracts, with stirring, for 20 min, and the precipitated
nucleic acids were removed by centrifugation at 48,400 × g for 45 min. The supernatant was dialyzed overnight against 20 mM
Tris-sulfate (pH 7.5).
Step 3. Ammonium sulfate precipitation.
The dialyzed enzyme
preparation was fractionated by stepwise addition of solid ammonium
sulfate to 10 to 60% saturation. At each step, the precipitate was
collected by centrifugation at 9,000 × g and dissolved
in 20 mM Tris-sulfate (pH 7.5). The active fractions at 10 to 30% were
dialyzed overnight against Tris-sulfate.
Step 4. Anion-exchange chromatography.
The dialyzed enzyme
was applied to a column (2.6 by 10 cm) of Sepharose Q Fast Flow
(Pharmacia), equilibrated with 20 mM Tris (pH 8.2). The column was
eluted at a flow rate of 7 ml/min with 1 liter of a linear gradient of
0 to 1 M NaCl in the same Tris buffer. Dehalogenase was eluted at 0.33 to 0.41 M NaCl. The active fractions were combined and dialyzed against
20 mM Tris-sulfate (pH 7.5).
Step 5. Hydroxylapatite chromatography.
The enzyme was
applied to a column (10 ml) of Hydroxylapatite Fast Flow (Calbiochem)
equilibrated with 20 mM Tris-sulfate (pH 7.5). The column was washed
with 100 ml of the same buffer and stepwise elution was carried out
with a linear gradient of 5 to 90 mM trisodium phosphate in 20 mM
Tris-sulfate (pH 7.5). The active fractions, which were eluted at 10 to
15 mM buffer concentrations, were pooled, dialyzed, and concentrated
with Centricon 30 (Amicon). The purified enzyme was stored at
20°C,
with a negligible loss of activity, for a period of over 1 month.
Molecular weight determination.
The native molecular weight
of the protein was determined by gel filtration on a High Prep 26/60
Sephacryl S-200 high-resolution column (Pharmacia). The medium was
equilibrated with 20 mM Tris-sulfate, pH 7.9. Cell extracts were
applied to the column and eluted with the same buffer at a flow rate of
1 ml/min. The column was calibrated with blue dextran (2,000 kDa),
albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa), and
ribonuclease A (13.7 kDa). The molecular weight of the partially
purified denatured dehalogenase was determined by sodium dodecyl
sulfate (SDS)-PAGE on a 12% gel (26). Rainbow molecular
weight markers (Amersham) were used as standards, and the gels were
visualized with Coomassie blue R-250.
N-terminal amino acid sequence determination.
Protein
samples were transferred onto a Hybond-P polyvinylidene difluoride
membrane (Amersham) from a denaturing gel by using a Bio-Rad
electroblotting system. Electroblotting was carried out in 10 mM
(cyclohexylamino)-1-propanesulfonic acid (CAPS) buffer, pH 11, containing 10% (vol/vol) methanol for 1 h at 75 V. The amino acid
sequence was determined with a G1000 protein sequencer (Hewlett-Packard).
Nucleotide sequence determination and alignment.
An
automated DNA sequencer (ALF-express; Pharmacia) was used to determine
the DNA sequences of the inserts, using Cy5-labelled nucleotides
according to the protocol provided by the supplier (Pharmacia). The
1.7-kb PstI fragment in pHKU104 was initially sequenced with
primers SP6 and T7. New oligonucleotide primers were then designed
according to the obtained sequencing data. The designed primers used
for sequencing in this study were as follows: S1, GGACA GCAGG GAAGC
CGTCA C; S2, CCATC TATCT GCGTG TTTGA; S3, TATGG GACAC AATTG GTGCG; S4,
TTTGC CAGGA GTCGC TTCCC; T1, GACTT TTGCG CCTGT CACGA; T2, GAGTA
CAAGA TAAGC TGATT; T3, ATATC CATAT CATTA CGGTC; and T4, TTTTT GTTAG
TTAGA TATCC. The fragment was sequenced in both directions. The
nucleotide sequences and the predicted amino acid sequences were
analyzed by University of Wisconsin Genetics Computer Group (GCG)
programs and by National Center for Biotechnology Information programs.
Nucleotide sequences were compared with those in the EMBL nucleotide
sequence data library. Amino acid sequences were compared with those in
the SWISS-PROT protein database. Alignment of the sequence of Chd1 with
those of other dehalogenases was performed with the GCG Pileup program.
Primer extension.
The transcriptional start site was mapped
by primer extension analysis (4). Total RNAs were isolated
from cultures of HKU103 with the High Pure RNA isolation kit
(Boehringer Mannheim). The Cy5-labelled primer
(5'-GTCTCCGAACACACGCTGA-3') was complementary to the
sequence at positions 822 to 804. The RNA-primer mixture, containing 5 µg of total RNA and a 2 µM concentration of the primer, was
incubated at 70°C for 10 min and quenched on ice for 1 min. The
reverse transcription reaction was performed by first-strand cDNA
synthesis with the SuperScript preamplification system (Gibco-BRL) according to the manufacturer's protocol. The size of the primer extension product was estimated by parallel sequencing reactions on
pHKU103 by using the same primer. The transcriptional start site was
determined with the ALF-express DNA sequencer.
Southern blot analysis.
The enhanced chemiluminescence
method (Amersham) was used for Southern hybridization. DNA fragments
were labelled according to the manufacturer's protocol and hybridized
to DNA-containing Hybond-N membranes.
Nucleotide sequence accession number.
The nucleotide
sequences presented here have been submitted to the EMBL database under
accession no. AJ005843.
 |
RESULTS |
Cloning of the structural gene (chd1) for the cryptic
haloacid dehalogenase from MBA4.
Among 1,200 ampicillin-resistant transfectants, five putative dehalogenase-positive
clones, which produced white precipitates upon addition of silver
nitrate, were obtained. Total protein extracts were prepared from
these putative dehalogenase-producing clones and analyzed by
activity-stained PAGE. Clones 1, 3, 4, and 5 produced a
dehalogenase migrating similarly to DehIVa. On the other
hand, clone 2 produced a novel dehalogenase migrating slower than
DehIVa (data not shown). This dehalogenase was tentatively named
Chd1 to indicate its cryptic nature.
The corresponding plasmids of the clones were isolated and cut with
EcoRI restriction endonuclease. Figure
1A shows that they give different
restriction patterns, indicating their independence in origin (lanes 1 to 3, 5, and 6). In order to eliminate DehIVa-producing clones,
Southern blot analysis was carried out. Figure 1B shows that clones 1, 3, 4, and 5 (lanes 1, 3, 5, and 6, respectively) exhibited positive
signals when hybridized with a probe containing the hdlIVa
gene. This result suggested that four out of the five dehalogenase-producing clones contained DehIVa. Only clone 2 (lane 2) did not exhibit any hybridization signal. The structural gene for
Chd1 was cloned (see below) and used as a probe. Figure 1C shows the
specific hybridization of this chd1-containing probe with
DNA of the various clones and with the total DNA of MBA4.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 1.
Agarose gel electrophoresis of plasmids isolated from
various clones. (A) Ethidium bromide-stained gel. (B) Southern blot
hybridized with probes containing the hdlIVa gene. (C)
Southern blot hybridized with probes containing the chd1
gene. Lanes 1 to 3, 5, and 6 contain plasmid DNAs isolated from various
clones and digested with EcoRI. Lane 7 contains a plasmid
bearing the hdlIVa gene in a 1.6-kb EcoRI
fragment. Lane 4 contains a molecular weight (MW) ladder (lambda DNA
cut with HindIII and EcoRI). Lane 8 contains
an MBA4 total DNA digested with EcoRI.
|
|
Subcloning of the DNA fragment for sequence analysis.
The
plasmid pHKU100, isolated from clone 2, was ca. 50 kb in size. In order
to identify the location for the structural gene, chd1, of
the cryptic dehalogenase, the plasmid was subjected to further
subcloning. Plasmid DNA was partially digested with Sau3AI and ligated to the BamHI site of pSP73 (Promega). The
ligation products were transformed into E. coli TOP10F', and
transformants were screened for dehalogenase production. This produced
plasmid pHKU101, which contains chd1 in a 10-kb fragment.
Plasmid pHKU101 was then subjected to EcoRI digestion, and a
3-kb fragment conferring dehalogenase activity was cloned into pSP73 to
form pHKU102. This plasmid was then cleaved with PstI, and a
1.7-kb fragment was cloned into pSP73 in both orientations to
form pHKU103 and pHKU104. Subcloning of chd1 was confirmed
by the hybridization of the 1.7-kb PstI fragment to DNA of
all the subclones (data not shown). Cells harboring either
pHKU103 or pHKU104 were dehalogenase positive (data not shown). This
suggested that the 1.7-kb PstI fragment contains a promoter
that is functional in E. coli.
Nucleotide sequence of the chd1 gene and flanking
regions.
The nucleotide sequence of the 1,744-bp insert in pHKU103
was determined on plasmid DNA templates by an automated DNA sequencer (Pharmacia). Primers SP6 and T7, annealing to the nucleotide sequences flanking the insert, were used. Other primers corresponding to sequences found within the inserts were also used. The nucleotide sequence is given in Fig. 2A. An ORF
consisting of 840 nucleotides started from the ATG beginning at
position 574 and ended with codon TGA beginning at position 1414. This
sequence would encode a protein of 280 amino acid residues with a
predicted molecular weight of 29,939.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 2.
Structure of the chd1 gene. (A) Nucleotide
sequence. The 1.7-kb PstI fragment contains an ORF of 840 nucleotides putatively encoding a protein of 280 amino acids. The
deduced amino acid sequence is shown below the nucleotide sequence.
Possible 10 and 35 consensus sequences of E. coli and a
possible Shine-Dalgarno (SD) sequence are indicated. The
transcriptional start site is in boldface and underlined. The
underlined portion of the deduced protein sequence was confirmed by
direct N-terminal sequencing. (B) Mapping of the transcriptional start
site of chd1. The products of primer extension and a
parallel sequencing reaction were analyzed by the ALF-express DNA
sequencer. The gel image was generated by the sequencer. The sequence
illustrated represents positions 516 to 540. The end of the extension
product is determined to be the T (in boldface) at position 524.
|
|
Within the same reading frame another ATG codon starting at position
709 could give rise to a protein with a predicted molecular weight of
25,439. In order to define the initiation codon for Chd1, the
N-terminal amino acid sequence of the recombinant protein was
determined. The results showed that the nucleotide sequence corresponding to the N terminus started between the first and the
second ATG codons (Fig. 2A).
A postulated Shine-Dalgarno (GGAGA) region was found close to the first
ATG of the gene, beginning at position 564. Figure 2B is an image of
the primer extension result showing the start of the transcript at the
T at position 524. Possible
35 and
10 consensus sequences beginning
at positions 484 (TAGGGCCA) and 512 (GGAAATT)
were detected. Downstream of the structural gene, a putative
stem-loop structure was detected between nucleotides 1416 and 1438, followed by a stretch of T residues.
Enzyme purification and biochemical characteristics.
Total
protein extracts were prepared from cells harboring
pHKU103. The enzyme was purified 18.5-fold, with an overall yield of 15%, and the dehalogenase accounted for 5.5% of the total soluble cellular protein (Table 1). The purified
enzyme preparation was considered to be 90% homogeneous when
electrophoresed by denaturing PAGE (Fig.
3). The molecular mass of the
dehalogenase was estimated to be 58 kDa by gel filtration
chromatography on Sephacryl S-200, while in SDS-12% PAGE the apparent
molecular mass was 27 kDa.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 3.
SDS-PAGE of the purified dehalogenase on a 12% gel.
Lane 1, molecular mass standards. Lane 2, 15 µg of the purified
enzyme preparation. The gel was stained with Coomassie blue R-250.
Numbers on the left are molecular masses, in kilodaltons.
|
|
The purified enzyme was most active towards MBA, with specific
activities of 5.44, 1.5, 4.56, and 1.95 µmol of halide
released/min/mg of protein for MBA, MCA, 2MBPA, and 2MCPA,
respectively. When activities towards D- and
L-2MCPA were considered individually, the enzyme
was found to be active towards the L-isomer only. The enzyme was not active towards dichloroacetate or chlorobutane. The
Michaelis constant (Km) for MBA at 25°C over
the substrate range of 0.1 to 3.0 mM was 1.13 mM, and a
Vmax of 30 µmol/min/mg was calculated.
The pH curve was bell shaped, with optimum activity at pH 6.5. The
enzyme was also sensitive to heat treatment. A preincubation at 35°C
for 15 min abolished 20 to 25% of the enzyme activity. The
enzyme was not inactivated by incubation with 1 mM EDTA,
CaCl2, MnCl2, NiCl2,
ZnCl2, hydroxylamine, iodoacetate,
N-ethylmaleimide, or FeSO4 but was
effectively inhibited by HgCl2. The enzyme was partially inhibited by CuSO4 (41%), RbCl2
(70%), and
-mercuric chlorobenzoate (87%).
 |
DISCUSSION |
In this paper, we have reported the cloning and
characterization of a cryptic dehalogenase, Chd1, from B. cepacia MBA4. This dehalogenase was not detected previously in
MBA4 as visualized by activity-stained PAGE, which can differentiate
dehalogenases according to their electrophoretic mobilities. In
previous experiments using continuous-culture techniques, at least two
other dehalogenases were detected (41). The genes for these
previously identified dehalogenases were not isolated in the present
study. It is likely that many of the bacterial promoters did not
function properly in E. coli, leading to a lack of
expression. It is common for dehalogenases expressed in soil isolates
to not be expressed in E. coli (16, 25).
Moreover, many natural isolates do contain unexpressed cryptic
dehalogenases (16, 19, 25).
We have purified and characterized Chd1. It is a 2-haloacid
dehalogenase with substrate specificity towards the
L-isomer only. This protein, however, has some unique
properties. Unlike previously isolated dehalogenases for which the
optimal pH is alkaline (9, 11, 12, 24, 27, 30, 31, 46), the
present enzyme is most active at pH 6.5. Comparison of the ORF for Chd1
with those for other dehalogenases (Fig.
4) shows that Chd1 possesses a long
N-terminal peptide not found in other dehalogenases. Primer extension
results confirmed that the transcript is sufficient to provide a
polypeptide to start at the first AUG of the ORF. N-terminal amino acid
sequence determination also confirmed that the protein starts upstream
of the second in-frame methionine. The putative N-terminal sequence
also exhibited the signal peptide property of periplasmic enzymes at
Ser-Thr-Asn-Ala-Asn-Ala-
-Ala-Glu-Ala, where the arrow
indicates the postulated cleavage site (34). This fits well
with the N-terminal amino acid sequence of the purified protein, which
starts at Ala-Glu-Ala. Periplasmic proteins were isolated from cells
harboring pHKU103 by a quantitative method (1). This protein
fraction was shown to contain dehalogenase activity (data not shown).
Plasmid pHKU103 was also transformed into E. coli strain
IT41 (20), which contains a temperature-sensitive leader
peptidase gene. Figure 5 shows that
precursor molecules of Chd1 were detected, with a concomitant decrease
in the cleaved protein, in cells grown at a nonpermissive temperature
(compare lanes 3 and 4). These data strongly suggested that Chd1 is a
periplasmic protein.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of haloacid dehalogenases. The amino acid
sequences of haloacid dehalogenases from B. cepacia MBA4
(DehIVa and Chd1 [DehCrp1]) (accession no. Q51645
[29; also this study]), Pseudomonas sp.
strains CBS3 (DehCI and DehCII) (accession no. P24069 and P24070
[33]) and YL (LdexYL) (accession no. Q53464
[30]), P. putida AJ1 (HadL) (accession no.
A44830 [18]) and 109 (DehH109) (accession no. Q59728
[19]), X. autotrophicus GJ10 (DhlB)
(accession no. Q60099 [41]), P. fluorescens
(DhlVII) (accession no. Q59666 [16]), and
Moraxella sp. strain B (DehH2) (accession no. Q01399
[20]) are aligned. The numbers on the left are the
residue numbers of each amino acid sequence. The conserved residues are
boxed and shaded.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 5.
Accumulation of precursor proteins in a
temperature-sensitive leader peptidase mutant. IT41(pHKU103) cells were
grown at 30°C until an optical density at 600 nm of 0.55 was reached
and then were divided into two aliquots. The two cultures were then
incubated at 30 or 42°C. Total protein extracts were prepared from
samples taken at 0 and 60 min and analyzed on an activity-stained
gel. The substrate used for visualization of the dehalogenase was
MBA. "Cleaved" refers to cleaved dehalogenase.
|
|
Activity-stained PAGE analysis indicated that Chd1 has a smaller
relative mobility value than does DehIVa of MBA4. DehIVa is a
dimeric protein of 45 kDa with a subunit size of 23 kDa
(43). SDS-PAGE analysis of purified Chd1 suggested that it
has a subunit size of ca. 27 kDa. Its shorter migration distance in
activity-stained PAGE and the gel filtration chromatography results
indicate that Chd1 is most likely a dimer consisting of two identical
subunits. Thus far, most of the dehalogenases isolated are dimers
(21, 22, 29, 30, 43), although monomeric and tetrameric
dehalogenases have also been detected in nature (21, 24, 28,
44).
The GCG program FASTA has been used to search for sequences similar to
the chd1 gene sequence. No significant homology was discovered among sequences in the EMBL database. However, when the
National Center for Biotechnology Information program BLASTP was used
to search for similarity with the predicted sequence of Chd1, a few
dehalogenases showing significant amino acid sequence homology were
obtained. The observed lack of DNA sequence homology among the
dehalogenases is consistent with the hypothesis that the enzymes
resulted from specialization of existing hydrolases (23, 25, 43,
46).
The protein sequences of these dehalogenases were then compared with
the predicted Chd1 amino acid sequences by using the GCG program
BESTFIT. The gap creation penalty and the gap extension penalty set for
the BESTFIT program were 3 and 1, respectively. The similarities
with the other dehalogenases are as follows: B. cepacia MBA4
(32), 49% (HdlIVa); Pseudomonas sp. strain CBS3 (36), 50% (DehCI) and 42% (DehCII); Pseudomonas
sp. strain YL (33), 48%; P. putida AJ1
(21), 47% (HadL); P. putida 109 (22), 45% (DehH109); Xanthobacter autotrophicus GJ10
(44), 49% (DhlB); Pseudomonas fluorescens
(18), 47% (DhlVII); and Moraxella sp. strain B (23), 45% (DehH2). Phylogenetic analysis was
performed by using the PHYLIP package (version 3.5). A phylogenetic
tree of haloacid dehalogenases was constructed by the neighbor-joining method (35), with 100 bootstrapped replicates
(10). All the dehalogenases analyzed were closely related to
each other, with Chd1 most closely related to DehCI of
Pseudomonas sp. strain CBS3 and to DehIVa (data not shown).
Haloacid dehalogenases have also been isolated in other types of
bacteria, such as P. putida (2),
Rhizobium (7), Alcaligenes xylosoxidans subsp. denitrificans (6), and
Agrobacterium tumefaciens (37). However, no
significant homologies were detected by comparing the nucleotide or the
deduced amino acid sequences of these enzymes with those in the EMBL
database (5, 7). The molecular characterization of
dehalogenases awaits future investigation.
 |
ACKNOWLEDGMENTS |
We thank the Department of Zoology for determining the N-terminal
amino acid sequence of the purified protein. We also thank J. Felsenstein for the PHYLIP package and Y. Nakamura for E. coli IT41.
This work was supported by grant from the Hong Kong Research Grants
Council. L.S. thanks the University of Hong Kong for a studentship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Microbiology Laboratory, Department of Botany, The University of Hong
Kong, Pokfulam Rd., Hong Kong. Phone: (852) 2859 7013. Fax: (852) 2858 3477. E-mail: jshtsang{at}hkucc.hku.hk.
 |
REFERENCES |
| 1.
|
Ames, G. F.-L.,
C. Prody, and S. Kustu.
1984.
Simple, rapid, and quantitative release of periplasmic proteins by chloroform.
J. Bacteriol.
160:1181-1183[Abstract/Free Full Text].
|
| 2.
|
Barth, P. T.,
L. Bolton, and J. C. Thomson.
1992.
Cloning and partial sequencing of an operon encoding two Pseudomonas putida haloalkanoate dehalogenases of opposite stereospecificity.
J. Bacteriol.
174:2612-2619[Abstract/Free Full Text].
|
| 3.
|
Bergmann, J. G., and J. Sanik.
1957.
Determination of trace amounts of chlorine in naphtha.
Anal. Biochem.
29:241-243.
|
| 4.
|
Boorstein, W. R., and E. A. Craig.
1989.
Primer extension analysis of RNA.
Methods Enzymol.
180:347-369[Medline].
|
| 5.
|
Brokamp, A., and F. R. J. Schmidt.
1991.
Survival of Alcaligenes xylosoxidans degrading 2,2-dichloropropionate and horizontal transfer of its halidohydrolase gene in a soil microcosm.
Curr. Microbiol.
22:299-306.
|
| 6.
|
Brokamp, A.,
B. Happe, and F. R. J. Schmidt.
1997.
Cloning and nucleotide sequence of a D,L-haloalkanoic acid dehalogenase encoding gene from Alcaligenes xylosoxidans ssp. denitrificans ABIV.
Biodegradation
7:383-396.
|
| 7.
|
Cairns, S. S.,
A. Cornish, and R. A. Cooper.
1996.
Cloning, sequencing and expression in Escherichia coli of two Rhizobium sp. genes encoding haloalkanoate dehalogenases of opposite stereospecificity.
Eur. J. Biochem.
235:744-749[Medline].
|
| 8.
|
Cohen, S. N.,
A. C. Y. Chang, and L. Shu.
1972.
Nonchromosomal antibiotic resistance in bacteria: genetic transformation of E. coli by R-factor DNA.
Proc. Natl. Acad. Sci. USA
69:2110-2114[Abstract/Free Full Text].
|
| 9.
|
Davies, J. I., and W. C. Evans.
1962.
The elimination of halide ions from aliphatic halogen-substituted organic acids by an enzyme preparation from Pseudomonas dehalogenans.
Biochem. J.
82:50-51.
|
| 10.
|
Felsenstein, J.
1985.
Confidence limits on phylogenies: an approach using the bootstrap.
Evolution
39:783-791.
|
| 11.
|
Goldman, P.
1965.
The enzymatic cleavage of the carbon-fluorine bond in fluoroacetate.
J. Biol. Chem.
240:3434-3438[Free Full Text].
|
| 12.
|
Goldman, P.,
G. W. A. Milne, and D. B. Keister.
1968.
Carbon-halogen bond cleavage. III. Studies on bacterial halidohydrolases.
J. Biol. Chem.
243:428-434[Abstract/Free Full Text].
|
| 13.
|
Hall, B. G.,
S. Yokoyama, and D. H. Calhoun.
1983.
Role of cryptic genes in microbial evolution.
Mol. Biol. Evol.
1:109-124[Abstract].
|
| 14.
|
Hardman, D. J.
1991.
Biotransformation of halogenated compounds.
Crit. Rev. Biotechnol.
11:1-40[Medline].
|
| 15.
|
Hardman, D. J., and J. H. Slater.
1981.
The dehalogenase complement of a soil pseudomonad grown in closed and open cultures on haloalkanoic acids.
J. Gen. Microbiol.
127:399-405.
|
| 16.
|
Hill, K. E.,
J. R. Marchesi, and A. J. Weightman.
1999.
Investigation of two evolutionarily unrelated halocarboxylic acid dehalogenase gene families.
J. Bacteriol.
181:2535-2547[Abstract/Free Full Text].
|
| 17.
|
Holmes, D. S., and M. Quigley.
1981.
A rapid boiling method for the preparation of bacterial plasmids.
Anal. Biochem.
114:193-197[Medline].
|
| 18.
| Honnens, E., R. Reiting, A. Brokamp, and F. J. R. Schmidt. 1995. EMBL accession no. X94147.
|
| 19.
|
Hope, S. J., and J. H. Slater.
1995.
Cryptic dehalogenase and chloroamidase genes in Pseudomonas putida and the influence of environmental conditions on their expression.
Arch. Microbiol.
163:57-64[Medline].
|
| 20.
|
Inada, T.,
D. L. Court,
K. Ito, and Y. Nakamura.
1989.
Conditionally lethal amber mutations in the leader peptidase gene of Escherichia coli.
J. Bacteriol.
171:585-587[Abstract/Free Full Text].
|
| 21.
|
Jones, D. H. A.,
P. T. Barth,
D. Byrom, and C. M. Thomas.
1992.
Nucleotide sequence of the structural gene encoding a 2-haloalkanoic acid dehalogenase of Pseudomonas putida AJ1 and purification of the encoded protein.
J. Gen. Microbiol.
138:675-683[Medline].
|
| 22.
|
Kawasaki, H.,
T. Toyama,
T. Maeda,
H. Nishino, and K. Tonomura.
1994.
Cloning and sequence analysis of a plasmid encoded 2-haloacid dehalogenase gene from Pseudomonas putida no. 109.
Biosci. Biotechnol. Biochem.
58:160-163[Medline].
|
| 23.
|
Kawasaki, H.,
K. Tsuda,
I. Matsushita, and K. Tonomura.
1992.
Lack of homology between two haloacetate dehalogenase genes encoded on a plasmid from Moraxella sp. strain B.
J. Gen. Microbiol.
138:1317-1323[Medline].
|
| 24.
|
Klages, U.,
S. Krauss, and F. Lingens.
1983.
2-Haloacid dehalogenase from a 4-chlorobenzoate-degrading Pseudomonas spec. CBS3.
Hoppe-Seyler's Z. Physiol. Chem.
364:529-535[Medline].
|
| 25.
|
Köhler, R.,
A. Brokamp,
R. Schwarze,
R. H. Reiting, and F. R. J. Schmidt.
1998.
Characteristics and DNA-sequence of a cryptic haloalkanoic acid dehalogenase from Agrobacterium tumefaciens RS5.
Curr. Microbiol.
36:96-101[Medline].
|
| 26.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 27.
|
Little, M., and P. A. Williams.
1971.
A bacterial halidohydrolase: its purification, some properties and its modification by specific amino acid reagents.
Eur. J. Biochem.
21:99-109[Medline].
|
| 28.
|
Liu, J.-Q.,
T. Kurihara,
A. K. M. Quamrul Hasan,
V. Nardi-Dei,
H. Koshikawa,
N. Esaki, and K. Soda.
1994.
Purification and characterization of thermostable and nonthermostable 2-haloacid dehalogenases with different stereospecificities from Pseudomonas sp. strain YL.
Appl. Environ. Microbiol.
60:2389-2393[Abstract/Free Full Text].
|
| 29.
|
Mörsberger, F.-M.,
R. Müller,
M. K. Otto,
F. Lingens, and K. D. Kulbe.
1991.
Purification and characterization of 2-halocarboxylic acid dehalogenase II from Pseudomonas spec. CBS3.
Biol. Chem. Hoppe-Seyler
372:915-922[Medline].
|
| 30.
|
Motosugi, K.,
N. Esaki, and K. Soda.
1982.
Purification and properties of 2-haloacid dehalogenase from Pseudomonas putida.
Agric. Biol. Chem.
46:837-838.
|
| 31.
|
Motosugi, K.,
N. Esaki, and K. Soda.
1982.
Purification and properties of a new enzyme, DL-2-haloacid dehalogenase, from Pseudomonas sp.
J. Bacteriol.
150:522-527[Abstract/Free Full Text].
|
| 32.
|
Murdiyatmo, U.,
W. Asmara,
J. S. H. Tsang,
A. J. Baines,
A. T. Bull, and D. J. Hardman.
1992.
Molecular biology of the 2-haloacid halidohydrolase IVa from Pseudomonas cepacia MBA4.
Biochem. J.
284:87-93.
|
| 33.
|
Nardi-Dei, V.,
T. Kurihara,
T. Okamura,
J.-Q. Liu,
H. Koshikawa,
H. Ozaki,
Y. Terashima,
N. Esaki, and K. Soda.
1994.
Comparative studies of genes encoding thermostable L-2-halo acid dehalogenase from Pseudomonas sp. strain YL, other dehalogenases, and two related hypothetical proteins from Escherichia coli.
Appl. Environ. Microbiol.
60:3375-3380[Abstract/Free Full Text].
|
| 34.
|
Nielsen, H.,
J. Engelbrecht,
S. Brunak, and G. von Heijne.
1997.
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.
Protein Eng.
10:1-6[Abstract/Free Full Text].
|
| 35.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 35a.
| Sam, L., and J. S. H. Tsang. Unpublished
results.
|
| 36.
|
Schneider, B.,
R. Müller,
R. Frank, and F. Lingens.
1991.
Complete nucleotide sequences and comparison of the structural genes of two 2-haloalkanoic acid dehalogenases from Pseudomonas sp. strain CBS3.
J. Bacteriol.
173:1530-1535[Abstract/Free Full Text].
|
| 37.
|
Schwarze, R.,
A. Brokamp, and F. R. J. Schmidt.
1997.
Isolation and characterization of dehalogenases from 2,2-dichloropropionate-degrading soil bacterium.
Curr. Microbiol.
34:103-109[Medline].
|
| 38.
|
Senior, E.,
A. T. Bull, and J. H. Slater.
1976.
Enzyme evolution in a microbial community growing on the herbicide Dalapon.
Nature
263:476-479[Medline].
|
| 39.
|
Slater, J. H.,
A. T. Bull, and D. J. Hardman.
1997.
Microbial dehalogenation of halogenated alkanoic acids, alcohols and alkanes.
Adv. Microb. Physiol.
38:133-176[Medline].
|
| 40.
|
Slater, J. H., and S. J. Hope.
1995.
Interactions between populations of Pseudomonas putida leading to the expression of a cryptic dehalogenase gene (dehII).
World J. Microbiol. Biotechnol.
11:186-192.
|
| 41.
|
Tsang, J. S. H.
1987.
Ph.D. thesis.
University of Kent, Canterbury, United Kingdom.
|
| 42.
|
Tsang, J. S. H.,
D. J. Hardman, and A. T. Bull.
1988.
Cloning and expression of 2-haloalkanoic acid dehalogenase of Pseudomonas cepacia MBA4 in Escherichia coli and in Pseudomonas putida, p. 231-239.
In
S. T. Chang, K.-Y. Chan, and N. Y. S. Woo (ed.), Recent advances in biotechnology and applied biology. Chinese University Press, Hong Kong.
|
| 43.
|
Tsang, J. S. H.,
P. J. Sallis,
A. T. Bull, and D. J. Hardman.
1988.
A monobromoacetate dehalogenase from Pseudomonas cepacia MBA4.
Arch. Microbiol.
150:441-446.
|
| 44.
|
Van der Ploeg, J.,
G. van Hall, and D. B. Janssen.
1991.
Characterization of the haloacid dehalogenase from Xanthobacter autotrophicus GJ10 and sequencing of the dhlB gene.
J. Bacteriol.
173:7925-7933[Abstract/Free Full Text].
|
| 45.
|
Weightman, A. J., and J. H. Slater.
1980.
Selection of Pseudomonas putida strains with elevated dehalogenase activities by continuous culture growth on chlorinated alkanoic acids.
J. Gen. Microbiol.
121:187-193.
|
| 46.
|
Weightman, A. J.,
A. L. Weightman, and J. H. Slater.
1982.
Stereospecificity of 2-monochloropropionate dehalogenation by the two dehalogenases of Pseudomonas putida PP3: evidence for two different dehalogenation mechanisms.
J. Gen. Microbiol.
128:1755-1762[Medline].
|
Journal of Bacteriology, October 1999, p. 6003-6009, Vol. 181, No. 19
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yu, M., Faan, Y.-W., Chung, W. Y. K., Tsang, J. S. H.
(2007). Isolation and Characterization of a Novel Haloacid Permease from Burkholderia cepacia MBA4. Appl. Environ. Microbiol.
73: 4874-4880
[Abstract]
[Full Text]
-
Srinivasan, P., Abraham, E. G., Ghosh, A. K., Valenzuela, J., Ribeiro, J. M. C., Dimopoulos, G., Kafatos, F. C., Adams, J. H., Fujioka, H., Jacobs-Lorena, M.
(2004). Analysis of the Plasmodium and Anopheles Transcriptomes during Oocyst Differentiation. J. Biol. Chem.
279: 5581-5587
[Abstract]
[Full Text]
-
Tsang, J. S. H., Pang, B. C. M.
(2000). Identification of the Dimerization Domain of Dehalogenase IVa of Burkholderia cepacia MBA4. Appl. Environ. Microbiol.
66: 3180-3186
[Abstract]
[Full Text]